naomi kobayashi

Affiliation and department：
MISC (16)：

Kobayashi N, Kiriyama Y, Hikichi M, Miyajima S, Kuroda M, Utsumi T. PREDICTIVE SIGNIFICANCE OF BREAST CANCER SUBTYPES IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY. The Breast. 2013. 22. 1. S103
Kobayashi N, Hikichi M, Miyajima S, Utsumi T. Subtypes of screen-detected invasive breast cancer and symptomatic invasive breast cancer and their impact on survival. Cancer Research. 2012. 72. 24. Supplement 3:291s
内海俊明, 小林尚美, 平澤浩. 乳癌を究める細胞診・組織診. 外科. 2012. 74. 7. 690-694
Kobayashi N, Ushimado K, Hikichi M, Miyajima S, Utsumi T. Comparison Between Screen-detected Invasive Breast Cancer and Symptomatic Breast Cancer According to Immunohistochemical Intrinsic Subtypes. European Journal of Cancer. 2012. 48. 1. S85
Kazutaka Ejiri, Kazuyuki Minami, Hiroshi Toyama, Gen Kudo, Hidekazu Hattori, Naomi Kobayashi, Masaki Kato, Masanobu Ishiguro, Hirofumi Fujii, Makoto Kuroda, et al. Sentinel node navigation surgery with 99mTc-tin colloid in breast cancer: Radiation safety considerations. Open Medical Imaging Journal. 2012. 6. 89-96

ｍore...

Books (1)：

Lectures and oral presentations (59)：

Aromatase inhibitor as neoadjuvant hormone therapy for breast cancer
(European Breast Cancer Conference 9 2014)
当院における乳癌術後再発症例の検討
(第113回日本外科学会定期学術集会 2013)
HER2乳癌における術前化学療法の治療効果と予後に関する検討
(第113回日本外科学会定期学術集会 2013)
当院におけるstageIV乳癌の検討
(第21回日本乳癌学会学術総会 2013)
当院における手術可能浸潤性小葉癌38例の臨床病理学的特徴および予後の検討
(第21回日本乳癌学会学術総会 2013)

ｍore...

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page